Examination Report |
1 | TM-1 | 27 Jan 2017 |
10 | Documents in support of Show cause Hearing (SCH) | 02 Mar 2023 |
10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Mar 2023 |
11 | Journal Copy | 17 May 2023 |
12 | Certificate | 04 Aug 2023 |
2 | Reply to Exam Report (MIS-R) | 10 Jul 2017 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 10 Jul 2017 |
4 | Reply to Exam Report (MIS-R) | 14 Jul 2017 |
5 | Reply to Exam Report (MIS-R) | 07 Nov 2017 |
6 | Reply to Exam Report (MIS-R) | 27 Dec 2017 |
7 | Reply to Exam Report (MIS-R) | 14 Jun 2018 |
8 | Authorization Letter | 19 Sep 2022 |
9 | Documents in support of Show cause Hearing (SCH) | 02 Mar 2023 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Mar 2023 |
1 | Dispatching of Examination Report for : 3468044 via Email | 4876019 | 2116930 | 23 Jun 2017 |
2 | Hearing Notice (Show Cause) | 13912732 | 08 Aug 2022 | |
3 | Hearing Notice (Show Cause) | 14669119 | 20 Jan 2023 | |
4 | Tribunal Accepted Notice for : 3468044 | 14916568 | 5882039 | 07 Mar 2023 |
The application for Defahit was made on 27 January 2017.
The trademark applicant for Defahit is AKUMS DRUGS PHARMACEUTICALS.
Defahit is applied in class(es) 5.
Application for Defahit is on Registered stage.
Application Id allotted to Defahit is 3468044.
Trademark agent or attorney for the application is D.K. Lalwani & Co.
Defahit filed with the Intellectual property office as a WORD.